NCT02043145View on ClinicalTrials.gov

Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in Korea

CompletedOBSERVATIONAL
Enrollment

727

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
HyperhidrosisMuscle SpasticityGlabellar Lines
Interventions
BIOLOGICAL

botulinum toxin Type A

Botulinum toxin Type A (BOTOX®) as prescribed according to standard of care in clinical practice.

Trial Locations (1)

Unknown

Seoul

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY